Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — August 2023

Genmab — August 2023

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #86

    Hm, ser vi bort fra Bava er det medicinal på taberlisten i dag.

    1 Reply Last reply
    0
    • L Offline
      L Offline
      lahn1
      wrote on sidst redigeret af
      #87

      Groundhog day

      1 Reply Last reply
      0
      • J Offline
        J Offline
        JKY_VH
        wrote on sidst redigeret af
        #88

        "Den fede dame" har ikke sunget endnu Bulder;-)

        1 Reply Last reply
        0
        • R Offline
          R Offline
          Riis7
          wrote on sidst redigeret af
          #89

          Man kan ikke bruge den us kurs til meget,
          åbner altid under i dk:-)

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #90

            Næh, synes bare at jeg øjnede et halmstrå i de grønne farma-aktier i us i går. Og at det så skulle være overstået. Men futterne dykker igen. Trist.

            1 Reply Last reply
            0
            • R Offline
              R Offline
              Riis7
              wrote on sidst redigeret af
              #91

              vejret og aktierne er triste i dag:-)

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #92

                Spændende om vi får lidt mere at vide om innova tecvayli 301 i dag, siden de nu venter topline resultater allerede i år. Måske vil en godkendelse kunne nås til næste år, og så har vi Tivdak i 2. linje.

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #93

                  Ipad rettede TV til tecvayli

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #94

                    yes, we would really need to get further up the line to see additional revenue, and hopefully some data on other tumors

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #95

                      further not that much to expect this evening i guess... even though we should expect genmab at some point to mention something about GEN1047 DuoBody-CD3xB7H4

                      and GEN3009 DuoHexabody-CD37
                      ; they will have to make a decision at some point to continue or not

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #96

                        And also a confimation that we can expect data from 1042 and 1046 this year.

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #97

                          Right now an announcement that jnj has chosen to opt in on hex38 would be very useful. 😉

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Sukkeralf
                            wrote on sidst redigeret af
                            #98

                            Also a BL.A. in immunology with one of Genmabs own antibodies maybe

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #99

                              I think champagne consumption would show a nice spike in Denmark this evening in that case ;-). 0% chance is my guess

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #100

                                Så røg gen da i det mindste ud af top 7 på taberlisten.

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #101

                                  That was on Bulder. A BLA indeed has
                                  a chance and would also be very welcome

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #102

                                    Kort video: Deutsche Bank hæver kursmålet for Novo Nordisk, men samtidig er der kommet erstatningskrav mod selskabet samt mod Eli Lily. Bavarian Nordic opjusterer, og det samme gør Genmab, som kommer med regnskab senere torsdag. Zealand Pharmas aktiekurs er ramt af svingninger. Til gengæld går det godt for aktiekursen hos Hansa Biopharma. https://www.proinvestor.com/boards/114344

                                    1 Reply Last reply
                                    0
                                    • V Offline
                                      V Offline
                                      Vitus
                                      wrote on sidst redigeret af
                                      #103

                                      Genmab is back….nu nr 1 fra bunden ……tillid tillid 😞

                                      1 Reply Last reply
                                      0
                                      • B Offline
                                        B Offline
                                        Bullish
                                        wrote on sidst redigeret af
                                        #104

                                        hmm sku' man smide en sum efter en overraskelse i regnskabet

                                        1 Reply Last reply
                                        0
                                        • B Offline
                                          B Offline
                                          Bullish
                                          wrote on sidst redigeret af
                                          #105

                                          Der er slet ikke indpriset opjusteringen
                                          fra sidste uge

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper